Dr Luis Emanuel Rivera Hiraldo, MD | |
10300 Sw 216th St, Cutler Bay, FL 33190-1003 | |
(305) 253-5100 | |
Not Available |
Full Name | Dr Luis Emanuel Rivera Hiraldo |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 10300 Sw 216th St, Cutler Bay, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912484320 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 22473 (Puerto Rico) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Luis Emanuel Rivera Hiraldo, MD 2o31 Calle 21, Mirador De Bairoa, Caguas, PR 00727-1005 Ph: (939) 332-6135 | Dr Luis Emanuel Rivera Hiraldo, MD 10300 Sw 216th St, Cutler Bay, FL 33190-1003 Ph: (305) 253-5100 |
News Archive
Delaying the age when kids try alcohol or smoking decreases the likelihood that they will become dependent later in life. Effective interventions exist, but community disagreements about which programs to try can stymie decisions.
As food manufacturers, health organizations, and government turn their attentions to helping Americans reduce the amount of sodium in their diets, market research company, The NPD Group, reports that there is a gap between consumers' concerns about the amount of sodium in their diets and their consumption of low-sodium and sodium-free foods.
Researchers have made important progress towards a new diagnostic test for schistosomiasis, which could help the World Health Organization achieve its goal of interrupting transmission of the disease, and eventually eliminating it.
Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have found that the breast cancer drug tamoxifen gives white blood cells a boost, better enabling them to respond to, ensnare and kill bacteria in laboratory experiments. Tamoxifen treatment in mice also enhances clearance of the antibiotic-resistant bacterial pathogen MRSA and reduces mortality.
› Verified 7 days ago